Source:http://linkedlifedata.com/resource/pubmed/id/18466256
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2008-5-16
|
| pubmed:abstractText |
Transvenous electrical cardioversion (TVEC) has been developed for treatment of atrial fibrillation (AF) in horses. The relationship among patient variables, treatment response, and outcome in a typical referral population has not been evaluated.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0891-6640
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
609-15
|
| pubmed:meshHeading |
pubmed-meshheading:18466256-Animals,
pubmed-meshheading:18466256-Atrial Fibrillation,
pubmed-meshheading:18466256-Catheterization, Swan-Ganz,
pubmed-meshheading:18466256-Electric Countershock,
pubmed-meshheading:18466256-Female,
pubmed-meshheading:18466256-Heart Catheterization,
pubmed-meshheading:18466256-Horse Diseases,
pubmed-meshheading:18466256-Horses,
pubmed-meshheading:18466256-Male,
pubmed-meshheading:18466256-Sex Factors
|
| pubmed:articleTitle |
Transvenous electrical cardioversion of equine atrial fibrillation: patient factors and clinical results in 72 treatment episodes.
|
| pubmed:affiliation |
Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada. mcgurrin@uoguelph.ca
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|